Opioid response to clonidine test as a predictor of effectiveness of antidepressant treatments in chronic headache

E. Martignoni, F. Facchinetti, G. Sances, A. Costa, A. R. Genazzani, G. Nappi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In this study we evaluated the opioid response to clonidine administration in headache sufferers with depressive symptoms, to test the hypothesis that such pharmacological tools may help characterize the profile of the different types of chronic headache. The plasma β-endorphin (β-EP) levels were evaluated before and after clonidine administration (0.075 mg IV) in 34 headache patients, 11 suffering from chronic tension headache (CTH) and 23 from migraine with coexisting chronic tension headache (MCTH), prior to starting an antidepressive treatment with amitriptyline or ritanserin. As controls, we examined eight age-matched healthy subjects. Patients as a whole and in the MCTH group, but not the CTH group, showed β-EP levels significantly lower than controls. In all patients and in both CTH and MCTH groups, a blunted response to clonidine administration was observed. Treatments with antidepressive drugs were both effective on pain severity and HRSD score. Moreover, the patients showing the largest increase in plasma β-EP levels following clonidine injection reported a more evident clinical response to the treatments. These findings suggest that the opioid response to the clonidine challenge in chronic headache may well predict the clinical effectiveness of the therapy.

Original languageEnglish
Title of host publicationHeadache Quarterly
Pages86-90
Number of pages5
Volume3
Edition1
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Opioid response to clonidine test as a predictor of effectiveness of antidepressant treatments in chronic headache'. Together they form a unique fingerprint.

Cite this